新型冠狀病毒肺炎對癲癇影響的研究進展_Journal of Epilepsy

Authors：

趙明睿 ¹ , 何文斌 ¹ , 沈云娟 ² ,  張新定 ²

1. ;
2. ;

Corresponding?author：

張新定, Email: zhangxind@lzu.edu.cn

Keywords：

新型冠狀病毒肺炎; 癲癇; 影響

DOI：

10.7507/2096-0247.20220016

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

自新型冠狀病毒肺炎（Corona virus disease 2019，COVID-19）爆發以來，對癲癇患者的健康產生了一定影響，癲癇與COVID-19兩者合并存在并不少見。癲癇與COVID-19可相互作用，加重各自病癥，導致患者學習、工作和生活質量的明顯下降。及時認識COVID-19 對癲癇的影響，早期采取針對兩種疾病的有效治療，將極大地有利于患者康復。

Citation： 趙明睿, 何文斌, 沈云娟, 張新定. 新型冠狀病毒肺炎對癲癇影響的研究進展. Journal of Epilepsy, 2022, 8(1): 65-69. doi: 10.7507/2096-0247.20220016 Copy

1.	Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020, 382(18): 1708-1720.
2.	Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology, 2017, 88(3): 296-303.
3.	Kuroda N, Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav, 2020, 108: 107-122.
4.	Cabezudo-Garcia P, Ciano-Petersen NL, Mena-Vazquez N, et al. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology, 2020, 95(10): 1417-1425.
5.	Kubota T, Kuroda N. Exacerbation of preexisting neurological symptoms and COVID-19 severity in patients with comorbid neurological disorders and COVID-19: A systematic review. Clin Neurol Neurosurg, 2021, 200: 106349.
6.	Granata T, Bisulli F, Arzimanoglou A, et al. Did the COVID-19 pandemic silence the needs of people with epilepsy. Epileptic Disord, 2020, 22(4): 439-442.
7.	Anand P, Al-Faraj A, Sader E, et al. Seizure as the presenting symptom of COVID-19: A retrospective case series. Epilepsy Behav, 2020, 112: 107335.
8.	Lu L, Xiong W, Liu D, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study. Epilepsia, 2020, 61(6): 49-53.
9.	Li Y, Li H, Fan R, et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology, 2016, 59(3): 163-169.
10.	Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia. Int J Infect Dis, 2014, 29: 301-306.
11.	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet, 2020, 395(10223): 497-506.
12.	Miller WR, Von Gaudecker J, Tanner A, et al. Epilepsy self-management during a pandemic: Experiences of people with epilepsy. Epilepsy Behav, 2020, 111: 107238.
13.	Alkhotani A, Siddiqui MI, Almuntashri F, et al. The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy. Epilepsy Behav, 2020, 112: 107323.
14.	Assenza G, Lanzone J, Brigo F, et al. Epilepsy care in the time of COVID-19 pandemic in Italy: Risk factors for seizure worsening. Front Neurol, 2020, 11: 737.
15.	Huang S, Wu C, Jia Y, et al. COVID-19 outbreak: The impact of stress on seizures in patients with epilepsy. [J]. Epilepsia, 2020, 61: 1884-1893.
16.	Fonseca E, Quintana M, Lallana S, et al. Epilepsy in time of COVID-19: A survey-based study. Acta Neurol Scand, 2020, 142: 545-554.
17.	San-Juan D, Jiménez CR, Camilli CX, et al. Guidance for clinical neurophysiology examination throughout the COVID-19 pandemic. Latin American chapter of the IFCN task force - COVID-19. Clin Neurophysiol, 2020, 131(7): 1589-1598.
18.	Grippo A, Assenza G, Scarpino M, et al. Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the Italian Association of Neurophysiology Technologists (AITN). Neurol Sci, 2020, 41(9): 2345-2351.
19.	Assenza G, Lanzone J, Ricci L, et al. Electroencephalography at the time of Covid-19 pandemic in Italy. Neurol Sci, 2020, 41(8): 1999-2004.
20.	Pellinen J, Carroll E, Friedman D, et al. Continuous EEG findings in patients with COVID-19 infection admitted to a New York academic hospital system. Epilepsia, 2020, 61: 2097-2105.
21.	Petrescu AM, Taussig D, Bouilleret V. Electroencephalogram (EEG) in COVID-19: A systematic retrospective study. Neurophysiol Clin, 2020, 50(3): 155-165.
22.	Wirrell EC, Grinspan ZM, Knupp KG, et al. Care delivery for children with epilepsy during the COVID-19 pandemic: An international survey of clinicians. J Child Neurol, 2020, 35: 924-933.
23.	Grinspan ZM, Mytinger JR, Baumer FM, et al. Management of infantile spasms during the COVID-19 pandemic. J Child Neurol, 2020, 35(12): 828-834.
24.	Aledo Serrano á, Mingorance A, Jiménez Huete A, et al. Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective. Epilepsia, 2020, 61(6): 1312-1314.
25.	Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol, 2013, 49(4): 243-254.
26.	Peron A, La Briola F, Bruschi F, et al. Tuberous sclerosis complex (TSC), lymphangioleiomyomatosis, and COVID-19: The experience of a TSC clinic in Italy. Am J Med Genet A, 2020, 182: 2479-2485.
27.	Colmenero J, Rodriguez-Perálvarez M, Salcedo M, et al. Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients. J Hepatol, 2021, 74: 148-155.
28.	Terrazzano G, Rubino V, Palatucci AT, et al. An open question: Is it rational to inhibit the mTOR-dependent pathway as COVID-19 therapy. Front Pharmacol, 2020, 11: 856.
29.	Kuroda N. Decision making on telemedicine for patients with epilepsy during the coronavirus disease 2019 (COVID-19) crisis. Front Neurol, 2020, 11: 722.
30.	Willems LM, Balcik Y, Noda AH, et al. SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experience. Epilepsy Behav, 2020, 112: 107483.
31.	Asadi-Pooya AA, Attar A, Moghadami M, et al. Management of COVID-19 in people with epilepsy: Drug considerations. Neurol Sci, 2020, 41(8): 2005-2011.
32.	Kossoff EH, Turner Z, Adams J, et al. Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations. Epilepsy Behav, 2020, 111: 107181.
33.	Miocinovic S, Ostrem JL, Okun MS, et al. Recommendations for deep brain stimulation device management during a pandemic. J Parkinsons Dis, 2020, 10(3): 903-910.
34.	Abdulsalam MA, Abdulsalam AJ, Shehab D. Generalized status epilepticus as a possible manifestation of COVID-19. Acta Neurol Scand, 2020, 142: 297-298.
35.	Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: Results from an international registry. Gastroenterology, 2020, 159(2): 481-491.
36.	Swarz JA, Daily S, Niemi E, et al. COVID-19 infection presenting as acute-onset focal status epilepticus. Pediatr Neurol, 2020, 112: 7.
37.	Asadi-Pooya AA, Cross JH. Is wearing a face mask safe for people with epilepsy. Acta Neurol Scand, 2020, 142: 314-316.
38.	Lucey CR, Johnston SC. The transformational effects of COVID-19 on medical education. JAMA, 2020, 324: 1033-1034.
39.	Felix C. Clinical research in the time of COVID-19. Int J Radiat Oncol Biol Phys, 2020, 108(2): 489-490.
40.	Beniczky S, Blümcke I, Rampp S, et al. e-learning comes of age: web-based education provided by the International League Against Epilepsy. Epileptic Disord, 2020, 22(3): 237-244.

1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020, 382(18): 1708-1720.
2. Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology, 2017, 88(3): 296-303.
3. Kuroda N, Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav, 2020, 108: 107-122.
4. Cabezudo-Garcia P, Ciano-Petersen NL, Mena-Vazquez N, et al. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology, 2020, 95(10): 1417-1425.
5. Kubota T, Kuroda N. Exacerbation of preexisting neurological symptoms and COVID-19 severity in patients with comorbid neurological disorders and COVID-19: A systematic review. Clin Neurol Neurosurg, 2021, 200: 106349.
6. Granata T, Bisulli F, Arzimanoglou A, et al. Did the COVID-19 pandemic silence the needs of people with epilepsy. Epileptic Disord, 2020, 22(4): 439-442.
7. Anand P, Al-Faraj A, Sader E, et al. Seizure as the presenting symptom of COVID-19: A retrospective case series. Epilepsy Behav, 2020, 112: 107335.
8. Lu L, Xiong W, Liu D, et al. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study. Epilepsia, 2020, 61(6): 49-53.
9. Li Y, Li H, Fan R, et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology, 2016, 59(3): 163-169.
10. Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia. Int J Infect Dis, 2014, 29: 301-306.
11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet, 2020, 395(10223): 497-506.
12. Miller WR, Von Gaudecker J, Tanner A, et al. Epilepsy self-management during a pandemic: Experiences of people with epilepsy. Epilepsy Behav, 2020, 111: 107238.
13. Alkhotani A, Siddiqui MI, Almuntashri F, et al. The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy. Epilepsy Behav, 2020, 112: 107323.
14. Assenza G, Lanzone J, Brigo F, et al. Epilepsy care in the time of COVID-19 pandemic in Italy: Risk factors for seizure worsening. Front Neurol, 2020, 11: 737.
15. Huang S, Wu C, Jia Y, et al. COVID-19 outbreak: The impact of stress on seizures in patients with epilepsy. [J]. Epilepsia, 2020, 61: 1884-1893.
16. Fonseca E, Quintana M, Lallana S, et al. Epilepsy in time of COVID-19: A survey-based study. Acta Neurol Scand, 2020, 142: 545-554.
17. San-Juan D, Jiménez CR, Camilli CX, et al. Guidance for clinical neurophysiology examination throughout the COVID-19 pandemic. Latin American chapter of the IFCN task force - COVID-19. Clin Neurophysiol, 2020, 131(7): 1589-1598.
18. Grippo A, Assenza G, Scarpino M, et al. Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the Italian Association of Neurophysiology Technologists (AITN). Neurol Sci, 2020, 41(9): 2345-2351.
19. Assenza G, Lanzone J, Ricci L, et al. Electroencephalography at the time of Covid-19 pandemic in Italy. Neurol Sci, 2020, 41(8): 1999-2004.
20. Pellinen J, Carroll E, Friedman D, et al. Continuous EEG findings in patients with COVID-19 infection admitted to a New York academic hospital system. Epilepsia, 2020, 61: 2097-2105.
21. Petrescu AM, Taussig D, Bouilleret V. Electroencephalogram (EEG) in COVID-19: A systematic retrospective study. Neurophysiol Clin, 2020, 50(3): 155-165.
22. Wirrell EC, Grinspan ZM, Knupp KG, et al. Care delivery for children with epilepsy during the COVID-19 pandemic: An international survey of clinicians. J Child Neurol, 2020, 35: 924-933.
23. Grinspan ZM, Mytinger JR, Baumer FM, et al. Management of infantile spasms during the COVID-19 pandemic. J Child Neurol, 2020, 35(12): 828-834.
24. Aledo Serrano á, Mingorance A, Jiménez Huete A, et al. Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective. Epilepsia, 2020, 61(6): 1312-1314.
25. Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol, 2013, 49(4): 243-254.
26. Peron A, La Briola F, Bruschi F, et al. Tuberous sclerosis complex (TSC), lymphangioleiomyomatosis, and COVID-19: The experience of a TSC clinic in Italy. Am J Med Genet A, 2020, 182: 2479-2485.
27. Colmenero J, Rodriguez-Perálvarez M, Salcedo M, et al. Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients. J Hepatol, 2021, 74: 148-155.
28. Terrazzano G, Rubino V, Palatucci AT, et al. An open question: Is it rational to inhibit the mTOR-dependent pathway as COVID-19 therapy. Front Pharmacol, 2020, 11: 856.
29. Kuroda N. Decision making on telemedicine for patients with epilepsy during the coronavirus disease 2019 (COVID-19) crisis. Front Neurol, 2020, 11: 722.
30. Willems LM, Balcik Y, Noda AH, et al. SARS-CoV-2-related rapid reorganization of an epilepsy outpatient clinic from personal appointments to telemedicine services: A German single-center experience. Epilepsy Behav, 2020, 112: 107483.
31. Asadi-Pooya AA, Attar A, Moghadami M, et al. Management of COVID-19 in people with epilepsy: Drug considerations. Neurol Sci, 2020, 41(8): 2005-2011.
32. Kossoff EH, Turner Z, Adams J, et al. Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations. Epilepsy Behav, 2020, 111: 107181.
33. Miocinovic S, Ostrem JL, Okun MS, et al. Recommendations for deep brain stimulation device management during a pandemic. J Parkinsons Dis, 2020, 10(3): 903-910.
34. Abdulsalam MA, Abdulsalam AJ, Shehab D. Generalized status epilepticus as a possible manifestation of COVID-19. Acta Neurol Scand, 2020, 142: 297-298.
35. Brenner EJ, Ungaro RC, Gearry RB, et al. Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: Results from an international registry. Gastroenterology, 2020, 159(2): 481-491.
36. Swarz JA, Daily S, Niemi E, et al. COVID-19 infection presenting as acute-onset focal status epilepticus. Pediatr Neurol, 2020, 112: 7.
37. Asadi-Pooya AA, Cross JH. Is wearing a face mask safe for people with epilepsy. Acta Neurol Scand, 2020, 142: 314-316.
38. Lucey CR, Johnston SC. The transformational effects of COVID-19 on medical education. JAMA, 2020, 324: 1033-1034.
39. Felix C. Clinical research in the time of COVID-19. Int J Radiat Oncol Biol Phys, 2020, 108(2): 489-490.
40. Beniczky S, Blümcke I, Rampp S, et al. e-learning comes of age: web-based education provided by the International League Against Epilepsy. Epileptic Disord, 2020, 22(3): 237-244.

Previous Article
枕葉癲癇癥狀學研究進展
Next Article
癲癇與抗癲癇藥物影響男性生殖功能作用機制的研究進展

Journal of Epilepsy

新型冠狀病毒肺炎對癲癇影響的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content